English

cancer-patients / English

Stories published on Nov 15
  • Related stories in the last 90 days
  • Stories published on Nov 15

Saturday, Nov 15

00

Wins for Cabozantinib in Kidney Cancer Brain Mets, Aggressive Disease Subtype

www.medpagetoday.com

(MedPage Today) -- DENVER -- A majority of patients with non-locally treated brain metastases from kidney cancer remained free of metastatic progression for at least 6 months when treated with cabozantinib (Cabometyx), a small prospective…

21

Ivermectin for Kidney Cancer: Patients Have Questions, Clinicians Have Concerns

www.medpagetoday.com

(MedPage Today) -- DENVER -- A discussion about patient-centered issues in kidney cancer management focused considerable attention on the controversial antiparasitic ivermectin, which was not even on the program at the International Kidney…

14

Study on breast cancer and birth control shows how science can be distorted

www.cbsnews.com

The study sought to answer questions about how breast cancer risk differs by type of hormonal contraceptive. Doctors say the results won't change how they counsel patients.

04

Study exposes cancer care deficit for patients with learning disabilities

www.manchester.ac.uk

People in England with a learning disability have a higher risk of cancer, especially before age 50 , according to a study by researchers from The University of Manchester and The ChristieNHS Foundation Trust .

Friday, Nov 14

20

Dying cancer patient marries girlfriend at hospice bedside in emotional ceremony

nypost.com

A dying cancer patient has married his girlfriend after strangers rallied to organise an emotional ceremony at his hospice bedside.

19

Deep learning system could transform skin cancer detection with near-perfect accuracy

medicalxpress.com

Melanoma remains one of the hardest skin cancers to diagnose because it often mimics harmless moles or lesions. While most artificial intelligence (AI) tools rely on dermoscopic images alone, they often overlook crucial patient information…

Transforming colorectal cancer research with patient-derived xenograft models

www.news-medical.net

Patient-derived xenograft (PDX) models are emerging as a transformative tool in colorectal cancer (CRC) research, offering unparalleled insights into tumor biology, drug resistance, and personalized treatment approaches.

18

GLP-1s Tied to Big Survival Advantage in Colon Cancer Patients

www.medpagetoday.com

(MedPage Today) -- Patients with colon cancer and a history of treatment with GLP-1 receptor agonists for obesity had a 5-year mortality rate that was less than half the rate for patients who didn't take these drugs, according to a large…

GLP-1s linked to lower colon cancer mortality rates: Study

thehill.com

The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor agonists.

17

Combination immunotherapy for rare cancers shows improved efficacy and survival rates

medicalxpress.com

New results from a multicenter clinical trial show that combining immunotherapy drugs nivolumab and ipilimumab significantly improves treatment response in patients with advanced and difficult-to-treat cancers. The trial results have been…

15

14

How patients are helping cancer researchers to ask better questions – and find better answers

theconversation.com

Cancer patients are helping shape research that reflects real lives. This is Patient and Public Involvement – and it’s helping to improve research.

Shropshire hospitals trust first in the country to use new technology in cancer treatment

www.shropshirestar.com

New cameras which can monitor the radiation dose being given to cancer patients have been installed at a county hospital.

GLP-1 weight-loss medications linked to improved cancer survival in certain patients

www.foxnews.com

GLP-1 medications may help colon cancer patients live longer by reducing inflammation and improving metabolic health, UC San Diego researchers found in a 6,800-patient study.

13

Tiny bladder implant, TAR-200, eliminates cancer in 82% of patients

The TAR‑200 slow‑release bladder implant cleared tumours in 82% of patients with high‑risk non‑muscle‑invasive bladder cancer, offering a promising new treatment approach.

12

Surgery after immunotherapy boosts survival for liver cancer patients

medicalxpress.com

A new Cedars-Sinai Cancer study shows that patients with advanced liver cancer who receive immunotherapy to shrink their tumors have improved outcomes after liver transplant or tumor removal.

The innovative new treatment which could help cancer patients avoid surgery

www.independent.co.uk

Bladder cancer is the ninth most common cancer in the world, the fourth most common cancer in men, and the 11th most common cancer in women

UK study exposes cancer care deficit for patients with learning disabilities

medicalxpress.com

People in England with a learning disability have a higher risk of cancer, especially before age 50, according to a study by researchers from The University of Manchester and The ChristieNHS Foundation Trust.